Form 4 for MGNX MACROGENICS INC
Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-19 · accession 0000899243-21-045703 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-23 | 2021-11-19 | MGNX | BIOTECH TARGET N V | 10% | P - Purchase | $18.50 | +200.0K | 7.28M | +3% | +$3.70M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-19 | P | A | 200,000 | $18.50 | 7,275,564 | D | — | — |